当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
MenQuadfi, Meningococcal (Groups A, C, Y, W) Conjugate Vaccine
药品名称
MenQuadfi, Meningococcal (Groups A, C, Y, W) Conjugate Vaccine
承诺描述
Deferred pediatric study (MET61) under PREA to evaluate the immunogenicity and safety of MenQuadfi in infants and toddlers 6 through 23 months of age.